Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Regencell Bioscience Holdings Ltd (RGC)

Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,967,051
  • Shares Outstanding, K 494,489
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,580 K
  • EBIT $ 0 M
  • EBITDA $ -4 M
  • 60-Month Beta 2.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 170.26% (-7.29%)
  • Historical Volatility 258.12%
  • IV Percentile 64%
  • IV Rank 33.26%
  • IV High 310.58% on 07/03/25
  • IV Low 100.32% on 10/20/25
  • Expected Move (DTE 22) 8.95 (31.48%)
  • Put/Call Vol Ratio 0.50
  • Today's Volume 322
  • Volume Avg (30-Day) 2,016
  • Put/Call OI Ratio 2.05
  • Today's Open Interest 9,972
  • Open Int (30-Day) 9,083
  • Expected Range 19.48 to 37.38

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate 0.34
  • Number of Estimates 6
  • High Estimate 0.39
  • Low Estimate 0.30
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +3.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.50 +38.20%
on 01/02/26
69.00 -58.94%
on 01/08/26
+4.85 (+20.66%)
since 12/29/25
3-Month
10.33 +174.25%
on 11/25/25
69.00 -58.94%
on 01/08/26
+11.72 (+70.56%)
since 10/29/25
52-Week
0.09 +30,431.48%
on 02/13/25
83.60 -66.11%
on 06/16/25
+28.23 (+28,230.00%)
since 01/29/25

Most Recent Stories

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regencell Bioscience Holdings Limited - RGC

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ: RGC). Such...

RGC : 27.78 (-13.97%)
The Best AI for Picking Stocks, Ranked by Performance

AI can pick stocks, but that doesn't mean it will do a good job. Here's a look at how the choices made by 7 leading AIs performed over a 90-day time period.

SOUN : 8.99 (-7.22%)
SMCI : 29.76 (-4.65%)
HUT : 60.62 (-6.16%)
MLTX : 16.28 (+0.18%)
LRMR : 3.62 (-1.63%)
REPL : 7.41 (+0.68%)
ASTS : 119.20 (-1.67%)
RGC : 27.78 (-13.97%)
China’s ADR Avalanche: Pheton’s 90% Plunge Exposes Pump‑and‑Dump Perils

Pheton Holdings shares collapsed nearly 90% in minutes after a Bear Cave report accused the Nasdaq-listed health care company of being the target of a pump‑and‑dump scheme. The stock, which closed...

RYET : 1.0700 (-1.83%)
PHH : 0.3850 (-0.08%)
JYD : 3.38 (-3.43%)
CLEU : 1.0300 (+5.64%)
GILD : 139.26 (-0.33%)
PTHL : 0.9023 (+105.16%)
RGC : 27.78 (-13.97%)
1 Magnificent Stock-Split Stock to Buy Hand Over Fist in July and 1 to Completely Avoid

Investors can confidently pile into a stock up more than 55,000% since its IPO, but should shy away from an unproven company that's soared as much as 60,100% through the first half of 2025.

ORLY : 99.17 (-2.17%)
RGC : 27.78 (-13.97%)
Regencell Bioscience (NASDAQ: RGC): 5 Min Deep Dive

In the volatile world of small-cap stocks, few names have grabbed investor attention like Regencell Bioscience Holdings Ltd (NASDAQ: RGC). Once a thinly traded micro-cap, RGC has exploded in recent weeks,...

RGC : 27.78 (-13.97%)
Prediction: Wall Street's Latest Stock-Split Stock -- Up 60,120% Year-to-Date -- Is Going to Implode... It's Just a Matter of Time

The stock market's newest stock-split stock doesn't pass the sniff test.

NVDA : 191.18 (-0.18%)
IBKR : 75.18 (-0.36%)
AVGO : 327.78 (-1.64%)
ORLY : 99.17 (-2.17%)
FAST : 43.19 (-0.44%)
RGC : 27.78 (-13.97%)
Top 10 Trending Stocks on Yahoo Finance Right Now

In a day full of surprises, Yahoo Finance’s “Trending Now” leaderboard offers a snapshot of the stocks that investors can’t stop clicking on. The list cuts across sectors and market caps, with...

HBIO : 0.5356 (-6.46%)
LCID : 11.17 (+2.38%)
ANET : 148.17 (-1.32%)
AI : 12.15 (-7.46%)
BBY : 65.13 (-0.66%)
SBET : 9.25 (-7.22%)
UBER : 81.57 (+2.24%)
ELF : 85.22 (+0.28%)
CRM : 211.99 (-7.01%)
RGC : 27.78 (-13.97%)
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News

In today’s edition of Small Cap News Movers, we spotlight some of the most active and news-driven small-cap stocks. From biotech breakthroughs to tech partnerships and restructuring announcements, these...

CECO : 70.52 (+1.35%)
JAGX : 0.6852 (+1.44%)
EVLV : 6.36 (-1.85%)
LEG : 11.76 (+0.43%)
PONY : 14.29 (-8.92%)
RGC : 27.78 (-13.97%)
Regencell Bioscience (NASDAQ: RGC): 5 Min Deep Dive

In the volatile world of small-cap stocks, few names have grabbed investor attention like Regencell Bioscience Holdings Ltd (NASDAQ: RGC). Once a thinly traded micro-cap, RGC has exploded in recent weeks,...

RGC : 27.78 (-13.97%)
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week

Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.

GCTK : 2.25 (-34.02%)
TCBP : 0.5000 (-67.53%)
ABBV : 223.68 (+2.29%)
ATNM : 1.2200 (unch)
RGC : 27.78 (-13.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Regencell Bioscience Holdings Limited is an early-stage bioscience company which focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum...

See More

Key Turning Points

3rd Resistance Point 38.66
2nd Resistance Point 36.15
1st Resistance Point 34.22
Last Price 27.78
1st Support Level 29.78
2nd Support Level 27.27
3rd Support Level 25.34

See More

52-Week High 83.60
Fibonacci 61.8% 51.70
Fibonacci 50% 41.85
Fibonacci 38.2% 31.99
Last Price 27.78
52-Week Low 0.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar